Literature DB >> 31066809

Crohn's disease - treatment with biological medication.

Cyrla Zaltman1,2, Heda Amarante1,2, Marta Machado Brenner1, Marcia Henriques Magalhaes Costa1,2, Cristina Flores1, Raquel Franco Leal1,3, Jair Francisco de Santana Grain1,2, Marco Zeroncio1,2.   

Abstract

The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31066809     DOI: 10.1590/1806-9282.65.4.554

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

1.  Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.

Authors:  Sarah C Davies; Tran M Nguyen; Claire E Parker; John K MacDonald; Vipul Jairath; Reena Khanna
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12

2.  Barbaloin Attenuates Mucosal Damage in Experimental Models of Rat Colitis by Regulating Inflammation and the AMPK Signaling Pathway.

Authors:  Ling Gai; Likai Chu; Rui Xia; Qian Chen; Xingwei Sun
Journal:  Med Sci Monit       Date:  2019-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.